Navigation Links
Scientists form alliance to develop nanotoxicology protocols
Date:9/9/2008

ZRICH, Switzerland -- Sept. 9, 2008 -- A team of materials scientists and toxicologists announced the formation of a new international research alliance to establish protocols for reproducible toxicological testing of nanomaterials in both cultured cells and animals. The International Alliance for NanoEHS Harmonization (IANH) was unveiled today at Nanotox 2008, one of the world's largest biennial nanotoxicological research meetings.

"When this team of scientists from Europe, the U.S., and Japan are able to get the same results for interactions of nanomaterials with biological organisms, then science and society can have higher confidence in the safety of these materials," said Kenneth Dawson, of University College Dublin and current chair of the IANH team.

Nanotechnology provides the opportunity for enabling new products that could meet a wide range of societal needs, but concerns over potential environmental, health and safety impacts of these materials may limit their adoption. Multiple organizations including the Organization for Economic Co-operation and Development (OECD) and the International Nanotechnology Conference for Communication and Cooperation (INC) have highlighted the importance of international collaboration to accelerate understanding of nanotechnology implications for society. This alliance, IANH, was established by leading materials and toxicological researchers to address this need.

Although Andrew Maynard, a leading scientist in this area, is not a member of this alliance, he sees the need for this effort. "This initiative is a major step toward ensuring hazard evaluations of emerging nanomaterials that are both relevant and reproducible," said Andrew Maynard, Chief Scientist, Project on Emerging Nanotechnologies, Woodrow Wilson International Center for Scholars in Washington, D.C.

The IANH team includes researchers from Germany: Wolfgang Kreyling of Helmholtz Institute; from Ireland: Kenneth Dawson of
'/>"/>

Contact: Vicki Colvin
colvin@rice.edu
713-348-5741
Rice University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. UK scientists working to help cut ID theft
2. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
3. Comet probes reveal evidence of origin of life, scientists claim
4. Scientists link fragile X tremor/ataxia syndrome to binding protein in RNA
5. Male elephants get photo IDs from scientists
6. Scientists retrace evolution with first atomic structure of an ancient protein
7. Muscle mass: Scientists identify novel mode of transcriptional regulation during myogenesis
8. Carnegie Mellon scientists develop nanogels that enable controlled delivery of carbohydrate drugs
9. Clemson scientists shed light on molecules in living cells
10. Scientists tackle mystery mountain illness
11. T. rex quicker than Becks, say scientists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2015)... Conn. , Feb. 12, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... has filed provisional patent 62/113114 for DISTRIBUTED ... DEVICES. The patent further establishes NXT-ID,s position ... its intellectual property portfolio the ability for multiple devices ...
(Date:2/5/2015)... RESEARCH TRIANGLE PARK, North Carolina , ... in sein 35. Jahr als spezialisiertes Logistikunternehmen ... seine Position als einzige klinische Logistikfirma (Clinical ... soll. Die Kernbotschaft der neuen Kampagne lautet ... Protokollen und Lieferungen. Foto: ...
(Date:2/5/2015)... Jan. 27, 2015   Marvin Test ... deployed, innovative test solutions for military, aerospace, ... of its TS-323 GENASYS Test Platform ... (LMSSC). GENASYS is a high-performance PXI-based system ... applications that require performance functional testing. GENASYS ...
Breaking Biology News(10 mins):NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4
... how heat shock protein 90 gets steroid receptors into ... lead to targeted therapies for hormone-driven cancers, such as ... College of Georgia researchers say. "We are trying ... proper conformation so they work," says Dr. Ahmed Chadli, ...
... E. Gardiner has received the ASHS Outstanding International Horticulturist ... has been given the award in recognition of her ... Gardiner will be presented with the award on 25 ... Louis, Missouri. Dr. Gardiner is co-editor of the ...
... addressed to President Barack Obama and the United States ... currently stated objectives in limiting the climatic disruption are ... clear leadership towards meet the objectives of the 1992 ... a "global climatic catastrophe". In part, ...
Cached Biology News:Targeting helpers of heat shock proteins could help treat cancer, cardiovascular disease 2Leading scientists and scholars urge action on climate issues 2
(Date:3/3/2015)... SAN DIEGO and TORONTO, March 3, 2015 /PRNewswire/ - ... company developing new therapeutics and molecular diagnostics that target ... for the quarter and seventh-month period ended December 31, ... changed its fiscal year end from May 31 to ... periods we are reporting today are for the quarter ...
(Date:3/3/2015)... , March 3, 2015 NASA astronaut Scott ... this month to spend a year living and working on ... interviews from 5:30 to 7 a.m. EDT Monday, March 9. ... as he completes the final weeks of his training. ... video on NASA Television highlighting his mission training and previous ...
(Date:3/3/2015)... 2015 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") ... for odour control projects in North America , ... . "Bidding activity in 2015 continues to be ... a high volume year for bidding in 2014, we are pleased ... recent orders reflect the organization,s renewed focus on select market segments ...
(Date:3/3/2015)... 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... and Chief Executive Officer of Neurocrine Biosciences, will be ... The live presentation takes place on ... presentation will be webcast and may be accessed on ... Listeners are encouraged to visit the website approximately ...
Breaking Biology Technology:Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 2Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 7Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 8Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 9Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 10Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 11Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 12NASA Astronaut Scott Kelly Available for Interviews before One-Year Space Station Mission 2
... July 24 The Global Probiotics Council,(GPC), a ... Yakult Honsha,Co., Ltd., announced the two awardees who ... Research (YIGPRO) today. The program was,created to identify ... to,the advancement of probiotics and gut microbiota research ...
... Poniard,Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical ... hold a conference call to discuss,the Company,s second ... update on the clinical development plan for picoplatin, ... and chief,executive officer, Ronald A. Martell, president and ...
... Cara Therapeutics, Inc.,announced today that it had ... its original $24 million Series C financing ... led by new investor, Devon Park Bioventures, ... participating,in the round included; Ascent Biomedical Ventures, ...
Cached Biology Technology:Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research 2Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research 3Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research 4Poniard Pharmaceuticals to Host Second Quarter 2008 Financial Results Conference Call on July 31 2Cara Therapeutics Secures $12.3 Million in Series C Extension Financing 2
We offer solid and solution phase peptide synthesis including a whole range of modifications. Please send the details of your peptide synthesis need to info@rpeptide.com...
... Kit - Monolayer is a system designed for ... monolayer in a serum-free environment. The kit contains ... has been optimized for neural stem cell expansion ... & Development 10 :3129). Human fibroblast growth ...
... DNA Polymerase I from ... DNA polymerase. The enzyme also ... activities.1 The 5'?3' exonuclease activity ... nicks and gaps in the ...
... E. coli strain containing an overproducing ... M-MLV Reverse Transcriptase catalyzes the polymerization of ... hybrids(1). Full-length copies of large mRNAs, >10 ... has a much lower RNase H activity ...
Biology Products: